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Abstract
Background: In addition to its well-known expression in dorsal telencephalic progenitor cells,
where it regulates cell proliferation and identity, the transcription factor Pax6 is expressed in some
ventral telencephalic cells, including many postmitotic neurons. Its functions in these cells are
unknown.
Results: We generated a new floxed allele of Pax6 and tested the consequences of a highly specific
ventral telencephalic depletion of Pax6. We used the Six3A1A2-Cre allele that drives production of
Cre recombinase in a specific region of Pax6-expression close to the internal capsule, through
which thalamic axons navigate to cerebral cortex. Depletion in this region caused many thalamic
axons to take aberrant routes, either failing to turn normally into ventral telencephalon to form
the internal capsule or exiting the developing internal capsule ventrally. We tested whether these
defects might have resulted from abnormalities of two structural features proposed to guide
thalamic axons into and through the developing internal capsule. First, we looked for the early
pioneer axons that project from the region of the future internal capsule to the thalamus and are
thought to guide thalamocortical axons to the internal capsule: we found that they are present in
conditional mutants. Second, we examined the development of the corridor of Islet1-expressing
cells that guides thalamic axons through ventral telencephalon and found that it was broader and
less dense than normal in conditional mutants. We also examined corticofugal axons that are
thought to interact with ascending thalamocortical axons, resulting in each set providing guidance
to the other, and found that some are misrouted to lateral telencephalon.
Conclusion: These findings indicate that ventral telencephalic Pax6 is important for formation of
the Islet1-expressing corridor and the thalamic and cortical axons that grow through it. We suggest
that Pax6 might affect thalamic axonal growth indirectly via its effect on the corridor.
Background
The cerebral cortex receives most of its sensory innerva-
tion via thalamocortical axons, which start to form at
about embryonic day 12.5 (E12.5) in mice. Thalamic
axons initially grow antero-ventrally through the dien-
cephalon before turning sharply laterally, avoiding ven-
tral diencephalic regions containing the hypothalamus
and forming the internal capsule in ventral telencephalon.
Published: 5 June 2009
Neural Development 2009, 4:19 doi:10.1186/1749-8104-4-19
Received: 4 February 2009
Accepted: 5 June 2009
This article is available from: http://www.neuraldevelopment.com/content/4/1/19
© 2009 Simpson et al.; licensee BioMed Central Ltd. 
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 18
(page number not for citation purposes)
Neural Development 2009, 4:19 http://www.neuraldevelopment.com/content/4/1/19After exiting the internal capsule, axons turn dorsally to
reach cortex from about E13.5 [1,2]. Previous studies have
indicated two major mechanisms likely to guide advanc-
ing thalamic growth cones into and through ventral telen-
cephalon [3-9]. First, several studies have suggested that a
transient group of ventral telencephalic neurons project
pioneer axons to the thalamus by E12.5, providing guid-
ance for reciprocal thalamocortical axons [4,6,8-14]. Sec-
ond, work by Lopez-Bendito et al. [15] showed that cells
migrate from the lateral ganglionic eminence (LGE) to
form a ventral telencephalic permissive corridor marked
by expression of the transcription factor Islet1, through
which thalamocortical axons grow.
Many transcription factors well-known for their functions
in early patterning of the developing nervous system also
have important functions in subsequent regulation of
axonal navigation, by influencing the responses of grow-
ing axons and/or the deployment of guidance cues [16-
18]. Pax6 is one such factor. In mice lacking Pax6, tha-
lamic axons fail to navigate correctly in the ventral telen-
cephalon and a normal internal capsule does not form
[12,19-21]. The mechanism of action of Pax6 in thalamo-
cortical axonal development is unknown.
A critical step towards understanding how Pax6 regulates
thalamocortical development is to define its site(s) of
action. Comparing Pax6's spatio-temporal pattern of
expression with the timetable of thalamocortical tract for-
mation indicates that Pax6 could influence guidance by
actions at the origin of the tract and/or in its target and/or
in intermediate tissue [1,2,4-6,19,22-24]. Pax6 is
expressed in the embryonic thalamus before thalamic
axons develop [19,20,23-28]. Previous experiments using
a co-culture approach have indicated that Pax6 is required
in the thalamus for thalamocortical axons to navigate
through ventral telencephalon [20]. Pax6 is expressed in
the cerebral cortex from before the time when thalamic
axons reach it [27,29,30]. A recent study by Pinon et al.
[31] reported normal thalamocortical tract development
following targeted deletion of Pax6 specifically in cerebral
cortex from before the time of thalamocortical develop-
ment, suggesting that Pax6 is not required in the cortex for
thalamic axonal guidance. Pax6 is expressed by some ven-
tral telencephalic cells in the vicinity of the internal cap-
sule at the time when thalamocortical axons are
navigating through this intermediate region
[19,27,32,33]. Its functions in these ventral cells are
unknown; a logical extension of previous work is to inves-
tigate whether Pax6 in this region contributes to the gen-
eration of normal thalamocortical projections and, if so,
how. These issues form the focus of the present study.
We addressed the possibility that normal expression of
Pax6 in ventral telencephalic cells around the internal
capsule is required for normal thalamocortical develop-
ment. We generated a new floxed allele of Pax6 and
crossed it with a strain of mice in which Cre recombinase
expression is restricted to a very specific Pax6-expressing
region of ventral telencephalon around the future internal
capsule from before E12.5. This resulted in an early deple-
tion of Pax6-expressing cells in this region and caused
many thalamic axons to take aberrant routes. We tested
possible mechanisms for these axonal defects and found
that the Islet1-expressing corridor that normally guides
thalamocortical axons failed to develop normally in con-
ditional mutants.
Results
Generation of the floxed Pax6 allele
In the floxed allele of Pax6 (Figure 1A), loxP sites flank
exons 5, 5a and 6, which encode the paired domain and
are essential for Pax6 function [34]. Cre-mediated dele-
tion of these exons was predicted to cause a nonsense
frame-shift in the remaining transcript, which includes
sequences encoding the second DNA binding domain, the
Pax6 homeodomain. As the loxP sites were inserted into
non-conserved intronic regions of the Pax6 gene the
floxed allele was predicted to function normally. Pax6loxP/
loxP mice are viable, fertile and phenotypically indistin-
guishable from wild-type mice (n > 100), both on gross
morphology and in sectioned material, and express Pax6
normally (Additional file 1A-B").
To establish that the Pax6loxP allele could generate a phe-
notype similar to that caused by the commonly used
Pax6SeyEd loss-of-function allele, we used mice that express
Cre recombinase in oocytes under the control of the Zp3
(zona pellucida glycoprotein 3) promoter to generate a
line carrying the deleted allele, Pax6loxPΔ [35]. Pax6loxPΔ/loxPΔ
embryos were negative for Pax6 protein as determined by
immunohistochemistry with antibodies that recognize
epitopes encoded within or 3' to the paired domain [36]
(Additional file 1C', C"). Pax6SeyEd/SeyEd embryos showed
very faint immunoreactivity for Pax6 (Additional file 1D',
D"), most likely because the antibodies' epitopes are 5' to
the mutation and could be included in a truncated protein
present at low level. Both Pax6loxPΔ/loxPΔ and Pax6SeyEd/SeyEd
embryos had similar severe defects of the eyes and face
[37,38] (data not shown) and telencephalon (Additional
file 1C, D).
Generating a restricted loss of Pax6 expression in ventral 
telencephalon
In the Six3A1A2-Cre transgenic mouse, Cre recombinase is
expressed in ventral telencephalon but in neither thala-
mus nor dorsal telencephalon [39]. The details of its
expression in ventral telencephalon were unknown and so
we crossed Six3A1A2-Cre mice to the reporter line Z/AP in
which human placental alkaline phosphatase (hPLAP) isPage 2 of 18
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[40]. We studied expression of hPLAP at the time when
thalamic axons are first navigating through ventral telen-
cephalon to cortex, E12.5 to E14.5.
At E12.5, hPLAP-expressing cells were detected in a ventral
domain of the medial ganglionic eminence (MGE; Figure
2A, white arrowhead), close to the region where thalamic
axons turn into the ventral telencephalon to form the
internal capsule. A cluster of Pax6-expressing cells was
located in ventral MGE in a similar position to the hPLAP
staining (Figure 2B, white arrowhead). This was separate
from a more lateral population of Pax6-expressing cells
derived from the pallium and forming part of the lateral
cortical stream (LCS) [41] (Figure 2B, C, black arrows).
The LCS comprises pallial- and subpallial-derived neural
progenitor cells derived from the pallial-subpallial border
(PSPB) that migrate to the developing structures of the
ventral telencephalon, including the piriform cortex and
amygdala. By E14.5, hPLAP-expressing cells were detected
more widely throughout not only the MGE but also the
LGE, still mainly ventral to the internal capsule (Figure
2D) in a region containing many Pax6-expressing cells
(Figure 2E). Based on these comparisons, we predicted
that the Six3A1A2-Cre transgene would produce a very spe-
cific loss of Pax6 expression from Pax6loxP/loxP mice, con-
fined to a region ventral to the developing internal
capsule.
Generation of the Pax6 conditional alleleFigure 1
Generation of the Pax6 conditional allele. (A) Targeting strategy showing the insertion of loxP sites into introns 4 and 6 
of murine Pax6, flanking exons that encode the paired type homeodomain. The final floxed Pax6 (Pax6loxP) and floxed null 
(Pax6loxPΔ) alleles are shown. (B, C) Correct targeting of the Pax6 locus in a series of embryonic stem cell clones was con-
firmed by Southern blot hybridization with probes (indicated by colored bars) proximal (B) and distal (C) to the insertion site; 
wt = wild type. (D) PCR amplification was used to genotype the Pax6loxP allele using primer set PCR1 and Pax6loxPΔ alleles using 
primer set PCR2 (positions of primers are indicated in (A)).Page 3 of 18
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tral telencephalic regions where Six3A1A2-Cre was
expressed at E12.5 and E14.5 in controls and conditional
knockouts (cKOs). We calculated the average number of
Pax6-expressing cells per section in the ventral MGE at
E12.5 and ventral MGE and LGE at E14.5 for cKOs and
controls (n = 4 embryos in each group). In E12.5 cKOs,
there was a greater than 50% reduction in the density of
Pax6-expressing cells in the ventral domain of the MGE
close to the region where thalamic axons turn into the
ventral telencephalon to form the internal capsule (Figure
2F–H; P < 0.01, Student's t-test). There was also a signifi-
cantly decreased density of Pax6-expressing cells in ventral
MGE and LGE in older E14.5 cKOs (Figure 2I–K; P < 0.03,
Student's t-test), although the difference was smaller than
at E12.5. The reason for this is most likely the continued
influx of non-deleted Pax6-expressing cells via the LCS
from more lateral telencephalic regions around the PSPB
[41,42] where Six3A1A2-Cre is not active. For the present
study, our important finding was that cKO E12.5 to 14.5
embryos have a depleted population of Pax6-expressing
cells ventral to the developing internal capsule at the time
when it starts to form. As anticipated, expression of Pax6
in the cortex and thalamus was unaffected in cKOs (Addi-
tional file 2).
Depletion of Pax6 in ventral telencephalon disrupts 
thalamocortical axonal development
To determine whether depletion of Pax6 in the ventral tel-
encephalon affected thalamocortical development, we
injected crystals of DiI into the dorsal thalamus at E12.5,
E14.5 and E16.5 (n ≥ 4 embryos in all groups; reported
differences between control and cKO embryos were con-
sistent in all embryos).
As previously described [5,10,43], injections into the dor-
sal thalamus of E12.5 control embryos retrogradely
labeled a population of cell bodies in the ventral part of
the MGE (Figure 3A-A"). The axons from these cells min-
gle with those exiting the dorsal thalamus and are postu-
lated to guide them as they traverse the ventral thalamus
towards the diencephalic-telencephalic border [44,45].
Figure 3B-B" shows a plane of section adjacent to the
main bundle of overlapping reciprocal projections, allow-
ing clear visualization of the trajectories of the two sets of
axons, which were oriented directly towards each other
(white arrowheads in Figure 3B"; the white arrow in Fig-
ure 3B indicates the region at the diencephalic-telen-
cephalic border shown at higher magnification in Figure
3B"). In addition, retrogradely labeled cell bodies were
seen in the ventral thalamus at this age (Figure 3C-C").
Injection of DiI into the dorsal thalamus of E12.5 cKO
mice also retrogradely labeled cell bodies in the ventral
MGE (Figure 3D-D"). There were abnormalities in the tra-
jectories of axons from the dorsal thalamus (Figure 3E-
E"): many did not follow a normal turn towards the ven-
tral telencephalon (for example, white arrowheads in Fig-
ure 3E", compare with Figure 3B"; the white arrow in
Figure 3E indicates the region at the diencephalic-telen-
cephalic border shown at higher magnification in Figure
3E"). As in controls, retrogradely labeled cell bodies were
observed in the ventral thalamus of cKO mice (Figure 3F-
F").
In E14.5 controls, the internal capsule was visible in bis-
benzimide stained sections as a cell sparse area (Figure
4A) that corresponded with the tightly fasciculated bun-
dle of thalamocortical axons labeled by DiI from the dor-
sal thalamus (Figure 4B). This bundle showed evidence of
defasciculation as it emerged from the internal capsule
but not before (Figure 4B'-B"). In E14.5 cKO mice, the
overall shape of the internal capsule was strikingly differ-
ent in bisbenzimide stained sections: the cell-sparse zone
spanning the diencephalic-telencephalic border appeared
disorganized (white arrow in Figure 4C) and only a nar-
row cell-sparse shaft extended across the ventral telen-
cephalon (black arrow in Figure 4C; compare with Figure
4A). DiI tracing from the thalamus revealed that, while
Depletion of ventral telencephalic Pax6 using the Six3A1A2-Cre alleleFigure 2 (see previous page)
Depletion of ventral telencephalic Pax6 using the Six3A1A2-Cre allele. (A, D) The Z/AP allele was used to reveal sites 
of Cre activity at E12.5 and E14.5 by expression of human placental alkaline phosphatase (hPLAP). Cre activity was restricted 
to bilateral patches in the ventral telencephalon (for example, white arrowhead in (A): note that brown stain elsewhere in lines 
of cells running throughout the tissue and along the pial surface is alkaline phosphatase reactivity in blood vessels). (B, C, E) 
Immunohistochemistry for Pax6 expression in the ventral telencephalon of normal embryos aged E12.5 and E14.5; the section 
in (B) is rostral to that in (C); the white arrowhead in (B) indicates a cluster of Pax6-expressing cells in the ventral medial gan-
glionic eminence (MGE) in a similar position to the hPLAP staining marked by the white arrowhead in (A); the section in (E) is 
of the same region as that shown in (D). Broken lines in (D, E) mark the internal capsule's ventral edge. (F, G) Immunohisto-
chemistry for Pax6 expression in the region indicated by the white arrowhead in (B) in control and conditional knockout 
(cKO) embryos at E12.5; quantification of the reduced density of Pax6-expressing cells in this region is shown in (H). (I, J) 
Immunohistochemistry for expression of Pax6 in the region shown in (D, E) in control and cKO embryos at E14.5; quantifica-
tion of the reduced density of Pax6-expressing cells in this region is shown in (K). Abbreviations: Cx, cortex; IC, internal cap-
sule; LCS, lateral cortical stream; LGE, lateral ganglionic eminence. Scale bars: 50 μm.Page 5 of 18
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diencephalic-telencephalic boundary in cKOs were simi-
lar in size to those in controls, an abnormally thin bundle
of thalamocortical axons crossed the ventral telen-
cephalon, suggesting that many failed to turn into the
internal capsule (Figure 4D–F). Much of the bundle of
axons descending through the diencephalon appeared to
end at the diencephalic-telencephalic border (bracket in
Figure 4E'). In addition, small numbers of axons left the
internal capsule along its length (in the region indicated
by the white arrowhead in Figure 4C) to grow in a ventral
direction (white arrowheads in Figure 4E'-E").
As at E14.5, the internal capsule of E16.5 cKO mice
appeared abnormally narrow (Figure 5A, B, between
white arrowheads). We confirmed that the overall size of
the internal capsule was reduced in E16.5 cKOs by sum-
ming the surface areas of the cell-sparse regions in serial
bisbenzimide-stained sections from each of three control
and three cKO embryos: values were significantly smaller
in cKO embryos (cKO, 3,791 ± 157 (standard error of the
mean) μm2; control, 5,180 ± 259 μm2; P < 0.02, Student's
t-test).
In E16.5 controls, DiI injections into the dorsal thalamus
labeled a thick fascicle of axons exiting the diencephalon,
turning to form the internal capsule and showing defascic-
ulation on exiting the internal capsule (Figure 5A', A"). In
contrast, DiI injections into the dorsal thalamus of cKO
mice labeled a bifurcated tract in which some axons pro-
jected along a normal route but others coursed ventrally,
in the direction of the hypothalamus, from the region
around which the normal tract bent sharply to cross the
diencephalic-telencephalic border (Figure 5B', B"). This
Disruption of thalamic axons in E12.5 Pax6 conditional knockoutsFigure 3
Disruption of thalamic axons in E12.5 Pax6 conditional knockouts. A rostral-to-caudal series of coronal 100 μm 
vibratome sections is shown for control and conditional knockout (cKO) embryos. (A-F) Bisbenzimide staining; (A', A"-F', F") 
corresponding low and high magnification views of DiI labeling from the dorsal thalamus (DT). Stars in (B', C', E') indicate the 
points of DiI crystal placement. Boxed areas in (A', D'), shown in (A", D"), respectively, demonstrate that retrogradely labeled 
neurons are present in ventral telencephalon (VTel) in both control and cKO embryos. In control embryos the axons from 
dorsal thalamus are oriented towards and intermingle neatly with the axons of ventral telencephalic neurons (white arrow-
heads in (B")); in cKOs, many thalamic axons are disorganized in their projection (white arrowheads in (E")); the white arrows 
in (B, E) indicate the centers of the regions shown in (B", E"). Both control and cKO embryos have retrogradely labeled cell 
bodies in the ventral thalamus (VT) (white arrowheads in (C", F")). Scale bars: 50 μm.Page 6 of 18
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Neural Development 2009, 4:19 http://www.neuraldevelopment.com/content/4/1/19abnormality corresponded with a cell-sparse region ven-
tral to the bend of the tract at the diencephalic-telen-
cephalic border seen in bisbenzimide-stained sections
(Figure 5B, red arrowheads). Most of these ventral projec-
tions continued roughly parallel with the diencephalic-
telencephalic border (Figure 5C–F, white arrowheads); a
few reached the ventral surface of the brain but many
extended no more than about 50 to 100 μm and ended
with spots of intense fluorescence that were probably
growth cones (for example, Figure 5F, left arrowhead). A
few turned either laterally (Figure 5C, D, green arrow-
heads) or medially (Figure 5C, yellow arrowheads).
In summary, our findings indicate that depletion of Pax6
from ventral telencephalic cells around the future and
developing internal capsule results in: the failure of many
thalamic axons to navigate normally from the vicinity of
the diencephalic-telencephalic border into the internal
capsule; and the exit of some thalamic axons from the
internal capsule in a ventral direction.
Possible mechanisms of action of ventral telencephalic 
Pax6 in thalamic axonal guidance
Previous studies have proposed two major mechanisms
guiding thalamic axons into the ventral telencephalon to
Disruption of thalamic axons in E14.5 Pax6 conditional knockoutsFigure 4
Disruption of thalamic axons in E14.5 Pax6 conditional knockouts. Coronal vibratome sections (200 μm) for control 
and conditional knockout (cKO) embryos injected with DiI in the dorsal thalamus: (A, C) bisbenzimide stained sections from 
(A) control and (C) cKO; (B-B") DiI labeling from control at increasing magnifications; (D-F) serial sections from cKO with 
central section (E) shown at increasing magnifications in (E', E"). In control embryos, the dense bundle of thalamic axons tra-
versing the diencephalon turns into the ventral telencephalon and travels through the internal capsule (IC). In cKOs, although a 
dense normal-appearing bundle of thalamic axons traverses the diencephalon (E), much of the bundle appears to end at the 
diencephalic-telencephalic border (bracket in (E')), fewer thalamic axons traverse the internal capsule and some of those axons 
that do penetrate the internal capsule exit it ventrally (at the position of the white arrowhead in (C); labeled axons exiting ven-
trally are indicated by white arrowheads in (E-E")). The white arrow in (C) indicates the diencephalic-telencephalic border. 
Scale bars: 50 μm.Page 7 of 18
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tral telencephalic neurons projecting from the vicinity of
the future internal capsule to the thalamus might provide
guidance for thalamocortical axons [6,8-10,43]. Second, a
set of Islet1-expressing cells derived from the LGE
migrates to form a permissive corridor in the ventral telen-
cephalon, through which thalamocortical axons grow
forming the internal capsule [15].
Work described above showed that the transient group of
ventral telencephalic neurons projecting to the thalamus
was present at an appropriate age in cKOs. We assessed the
size of the group. Counting individual neurons was not
sufficiently accurate since the DiI labeling was cytoplas-
mic and the cells were so densely packed with numerous
processes that they could not be resolved. We counted all
labeled pixels above a threshold (set to remove back-
ground) from each of a series of sections through these
groups of cells in four cKO and three control embryos.
This provided, for each embryo, a measure of the total
area of the retrogradely labeled cells, which we assume to
be proportionate to the number of cells since cell sizes
appeared similar in the two genotypes. We found no sig-
nificant difference in the average areas between the two
genotypes (control, 621 ± 146 (standard error of the
Disruption of thalamic axons in E16.5 Pax6 conditional knockoutsFigure 5
Disruption of thalamic axons in E16.5 Pax6 conditional knockouts. Coronal vibratome sections for control and condi-
tional knockout (cKO) embryos injected with DiI in the dorsal thalamus. (A, B) Bisbenzimide stained sections show narrowing 
of the internal capsule between the white arrowheads. (A'-B") Corresponding DiI labeled sections; boxed areas in (A', B') are 
shown in (A", B"), respectively. In cKOs, many thalamic axons do not turn across the diencephalic-telencephalic border (DTB) 
but descend ventrally towards the hypothalamus. This aberrant tract corresponds to a cell-free spur seen in bisbenzimide-
stained sections near the start of the internal capsule (red arrowheads in (B)). (C-F) High magnification optical sections from 
around the boxed area in (B"): many aberrant axons descend directly ventrally (white arrowheads) while a few loop out medi-
ally (yellow arrowheads) or project laterally into ventral telencephalon (green arrowheads). Scale bars: 50 μm.Page 8 of 18
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Student's t-test).
It remains possible that these pioneer neurons have
molecular defects preventing their normal guidance of
thalamic axons. The likelihood of this would have been
enhanced if these transient projections normally
expressed Pax6. To address this possibility, we combined
immunohistochemistry for Pax6 with DiI labeling of con-
trol brains at E12.5. We found no overlap between the
populations of cells expressing Pax6 in the ventral MGE
(Figure 6A, B; the population labeled with white arrow-
heads corresponds to that indicated by the white arrow-
head in Figure 2B) and projecting to the thalamus (Figure
6B, yellow arrowheads). This suggests that if these projec-
tions in cKOs do have molecular defects preventing them
fulfilling their guidance role, it would have had to have
been generated either indirectly, as a result of loss of Pax6
in other cells, or as a consequence of Pax6 loss earlier in
these cells' lineage (assuming that they did express Pax6
earlier and that Six3A1A2-Cre caused loss of any such
expression, which are formal but uncertain possibilities).
A more parsimonious explanation for the defective forma-
tion of the internal capsule in cKOs came from an analysis
of the permissive corridor in the ventral telencephalon of
cKOs. In E12.5 control embryos we observed the previ-
ously described distribution of Islet1-expressing cells
densely corralled into a well-defined corridor traversing
the mantle zone of the MGE (Figure 7A, C). In cKO mice,
Islet1-expressing cells were also distributed in a corridor
running in a similar position through the MGE but they
appeared more broadly distributed (Figure 7D). This dif-
ference was quantified in four control and four cKO E12.5
embryos. A series of sampling bins was laid across the cen-
tre of the corridor, starting from the pial surface (as shown
in Figure 7A), in two non-adjacent sections from each
embryo. Numbers of Islet1-expressing cells at each depth
from each embryo were averaged to give the density pro-
files shown in Figure 7B. Although the overall numbers of
Islet1-expressing cells in the entire sampling area were no
different in controls and cKOs (mean for controls, 117.0
cells per 10 bins; mean for cKOs, 116.2 cells per 10 bins),
the peak densities seen in the center of the corridor were
lower in cKOs. The distribution of Islet1-expressing cells
was broader in the ventral direction in cKOs: double-
headed arrows in Figure 7B indicate the widths of the dis-
tributions at half peak values. These data suggest that nor-
mal numbers of Islet1-expressing cells migrate from the
LGE but they are more scattered into ventral MGE in
cKOs, where Pax6-expressing cells are depleted. This dis-
ruption of the corridor might account for the thalamic
axonal navigation defects observed in cKOs.
Evidence for aberrant corticofugal axons in cKOs
Previous work has shown that ascending thalamocortical
axons intermingle with descending corticofugal axons in
the ventral telencephalon and this observation has led to
the suggestion that interactions between the two sets of
axons might be important for the guidance of each set
[3,4,21]. Since in cKOs some thalamic axons are derailed
before they reach the region ventral to the PSPB where
Ventral telencephalic pioneer neurons do not express Pax6Figu e 6
Ventral telencephalic pioneer neurons do not express Pax6. (A, B) Coronal vibratome sections from E12.5 control 
mice injected with DiI in the dorsal thalamus. After DiI diffusion, immunohistochemistry revealed cells expressing Pax6 (the 
most medial group is indicated by white arrowheads). (B) Under epifluoresence, the location of DiI retrogradely labeled cell 
bodies in the ventral telencephalon can be seen (yellow arrowheads). Retrogradely labeled cells do not express Pax6. Scale bar: 
50 μm.Page 9 of 18
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seemed possible that an interaction between the popula-
tions of thalamocortical and corticofugal axons might be
suboptimal, resulting in some descending cortical axons
taking aberrant trajectories. Following injections of DiI
into the thalamus of E14.5 and E16.5 cKOs, we observed
retrogradely labeled cell bodies in the cortex (Figure 8A),
indicating that corticothalamic projections are present.
We then injected DiI and DiA into the cortex at E16.5, as
shown in Figure 8B: this would result in both the retro-
grade labeling of thalamocortical axons and the antero-
grade labeling of corticofugal axons, thereby allowing any
aberrantly routed corticofugal trajectories to be identified.
Labeling of the axons between somatosensory cortex and
thalamus appeared normal (Figure 8D, F) but, while we
observed many axons labeled from the visual cortex in the
internal capsule of both controls and cKOs (Figure 8C, E),
some were seen in the lateral telencephalon of cKOs (Fig-
ure 8E, G, G') but not of controls (Figure 8C). These axons
could be followed to the pial surface of the lateral telen-
cephalon (Figure 8G, G') but not beyond. The likely expla-
nation of this finding is that some descending corticofugal
axons from visual cortex become misrouted in cKOs.
Discussion
In the telencephalon, Pax6 is considered a major regulator
of early dorsal patterning and development and its func-
tions in ventral telencephalon, where it is less widely
expressed, are obscure [27,42,46-49]. Our work indicates
that ventral telencephalic Pax6 expression plays an impor-
tant part in the development of the corridor that guides
thalamic axons through the ventral telencephalon
towards the cerebral cortex. Depletion of ventral telen-
cephalic Pax6-expressing cells causes a diluted and broad-
ened distribution of corridor cells and misrouting of some
thalamic axons, both around their region of entry into the
Broadening of the Islet-1-expressing corridor in E12.5 conditional knockoutsFigur  7
Broadening of the Islet-1-expressing corridor in E12.5 conditional knockouts. (A) Coronal section of the telen-
cephalon of an E12.5 control embryo showing immunohistochemistry for Islet1; the arrangement of bins used for counting 
Islet1-expressing cells across the corridor in control and conditional knockout (cKO) embryos is marked. (B) Graph shows 
the distributions of Islet1-expressing cells across the corridor: values plotted are mean densities per bin ± standard error of 
the mean (n = 4 embryos for both control and cKO data); black error bars and grey shading are for control data; red error 
bars and broken line without shading are for cKO data; double-headed arrows indicate the widths of the distributions at half 
their peak values (black arrow for control data, red arrow for cKO data). (C, D) Illustration of the finding: in cKO embryos 
Islet1-expressing cells spread more broadly from the corridor towards the ventral surface of the brain (at the bottom left of 
each panel) than in controls. Scale bars: 50 μm.Page 10 of 18
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Aberrant corticothalamic projections in conditional knockoutsFigu e 8
Aberrant corticothalamic projections in conditional knockouts. (A) Coronal section of E14.5 conditional knockout 
(cKO) cortex following injection of DiI in dorsal thalamus: retrogradely labeled cell bodies are visible, some are indicated by 
arrows. (B) Diagram of the forebrain showing sites of cortical injection of DiI (red in visual area 1 (V1)) and DiA (green in 
somatosensory area 1 (S1)). (C, D) Control E16.5 brains showing (C) DiI and (D) DiA label in the internal capsule (IC). (E, F) 
E16.5 cKO brains showing (E) DiI and (F) DiA label in the internal capsule; some aberrant DiI label from V1 was also seen 
traveling laterally (white arrowhead in (E)). (G, G') E16.5 cKO brains showing higher magnification of area indicted by the 
white arrowhead in (E): many labeled axons (arrowheads) are seen projecting to the pial surface. Scale bars: 50 μm.
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marized in Figure 9.
Generation of cKO embryos with Pax6 depletion restricted 
to cells ventral to the internal capsule
We have made a new floxed allele of the Pax6 gene in
which none of the loxP elements reside in an exon or in
any conserved sequence element with the aim of mini-
mizing the chance of interfering with the normal expres-
sion of the gene in the pre-deleted state. This offers a
different floxed allele to that generated by Ashery-Padan et
al. [50] in which one loxP site is in exon 4 upstream of the
first ATG site. Neither their nor our Pax6loxP/loxP mice show
any obvious morphological defects.
Pax6 is normally expressed at several sites in embryonic
ventral telencephalon. First, it is expressed in the progeni-
tor cells of the LGE; its expression here is much lower than
its expression on the dorsal side of the PSPB
[19,27,32,33]. Second, it is expressed in neurons in the
LCS that are derived from the vicinity of PSPB and migrate
to occupy the basolateral complex [41]. Third, Pax6-
expressing cells are located ventral to the developing inter-
nal capsule in the MGE; since these cells are present at
E12.5, when the very first LCS cells are occupying the lat-
eral part of the LGE, they might be derived from the pro-
genitor zone of the MGE rather than the LCS. Using a
Six3A1A2-Cre allele [39], we were able to obtain a highly
specific depletion of Pax6-expressing cells ventral to the
developing internal capsule at the age when thalamic
axons first turn into it. Cre recombinase was expressed
Summary of findingsFigure 9
Summary of findings. (A) In control embryos, Pax6-expressing cells (purple) are located ventral to the developing internal 
capsule; those located laterally comprise the lateral cortical stream migrating from the pallial-subpallial border (PSPB). Islet1-
expressing cells (green) migrate from the progenitor layer of the lateral ganglionic eminence (green arrow) to form the corri-
dor through which thalamocortical axons grow (curved black arrow). (B) In conditional knockout (cKO) embryos, there are 
fewer Pax6-expressing cells ventral to the internal capsule than normal (other populations of Pax6-expressing cells outside the 
region of Cre-mediated Pax6 deletion are not shown since they are not affected). Cells from the lateral ganglionic eminence 
migrate to form a corridor that is abnormally broad with a lower peak density of Islet1-expressing cells; many Islet1-expressing 
cells stray into the area depleted of Pax6 expression. Many thalamic axons fail to enter this abnormal corridor or exit it along 
its length.Page 12 of 18
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dorsal thalamus, nor in the cortex, and Pax6 continued to
be expressed as normal in these regions.
Comparison of thalamic axonal defects in Pax6-/- and 
Pax6 cKO embryos
The thalamocortical tract does not form in Pax6-/- mice
and rats [12,19-21]. Pax6-/- thalamic cells generate a large
bundle of axons that grow at the same time as, have the
same fasciculation pattern as, and extend initially along
the same route as wild-type thalamocortical axons. They
become misrouted as they cross into ventral telen-
cephalon. Many extend aberrantly into the hypothalamus
[12,21]. Others enter the internal capsule but then exit it
to enter the future amygdala in the ventral part of the ven-
tral telencephalon [21]; thalamic axons were also
observed taking this route when grown into Pax6-/- ventral
telencephalic slices in vitro [20]. Others enter the ventral
telencephalon abnormally ventrally, around the base of
the telencephalon [12,19]. In the cKOs described here, we
found evidence for less extreme versions of these defects:
although many thalamic axons navigated through the
internal capsule, others deviated ventrally towards the
hypothalamus (Figure 5B"); some of those that had devi-
ated ventrally towards the hypothalamus later projected
laterally into the ventral part of the ventral telencephalon
(green arrowheads in Figure 5C, D); some axons that did
turn into the internal capsule then exited it in a ventral
direction towards the amygdala (Figure 4E"). These find-
ings indicate that at least some of the defects of thalamo-
cortical navigation reported in Pax6-/- embryos are caused
by loss of Pax6 from ventral telencephalon.
It would be interesting to discover whether the degree of
Pax6 depletion in the region ventral to the developing
internal capsule influences the proportion of thalamic
axons that navigate correctly. Testing this possibility was
not possible here since the Six3A1A2-Cre allele produced a
depletion that was highly consistent from embryo to
embryo, as shown by the tight error bars on the data in
Figure 2H, K, and so there was no opportunity to correlate
a variable level of depletion with the phenotype. The
development of a new Cre-expressing line in which an
inducible form of Cre recombinase is expressed by all cells
restricted to the tissue ventral to the internal capsule
might allow this possibility to be tested, although finding
a suitable promoter will be a challenge. Nevertheless, our
data do show a clear requirement for normal Pax6 expres-
sion in this region for normal thalamic axonal navigation.
While it is conceivable that complete removal of Pax6
from the region ventral to the developing internal capsule
might reproduce the Pax6-/- phenotype in its entirety, pre-
viously published work indicates that the Pax6-/- thalamic
axonal phenotype is more likely to arise from a combina-
tion of thalamic and ventral telencephalic defects. Two
studies have applied methods to examine the effects of
loss of Pax6 selectively in cortex or thalamus on thalamo-
cortical development. While recent work with mice carry-
ing a cortex-specific deletion of Pax6 showed that Pax6 is
not required in the cortex for thalamocortical formation
[31], earlier work suggested that loss of Pax6 in thalamic
cells prevents its axons from responding appropriately to
ventral telencephalic guidance cues [20]. It seems most
likely, therefore, that ventral telencephalic defects in the
deployment of guidance cues combine with defects in the
ability of thalamic axons to respond to any cues that may
be present in embryos lacking Pax6 to give the full tha-
lamic axonal phenotype of the Pax6-/- embryo.
Mechanisms of aberrant thalamocortical axonal 
navigation in Pax6 cKO embryos
The axons in cKOs that fail to turn through the internal
capsule but stray ventrally, roughly parallel to the dien-
cephalic-telencephalic border, follow a route taken not
only by thalamic axons in Pax6-/- mutants, but also by at
least some thalamic axons in Emx2-/- [13], Mash1-/- [6],
Foxg1-/- [20] and Lhx2-/- [51] mutants. It is possible that
this is a default pathway taken by thalamic axons that fail
to be attracted into the region of the future internal cap-
sule. In these mutants, it has been suggested that the fail-
ure of attraction is due to defects of reciprocal projections
from the region of the internal capsule that would nor-
mally act as guidance cues [8,14,51]. In the case of Pax6-/-
mutants the dorsal thalamus is not innervated by pioneer-
ing axons from ventral telencephalon [14]. Our present
results show that, in normal embryos, this pioneering
population does not express Pax6 at the time when it
might provide guidance to thalamic axons, although we
can not exclude the possibility that it is derived from cells
that expressed Pax6 previously, and that it does still inner-
vate the thalamus in cKOs with depletion of Pax6 only in
ventral telencephalon. It is possible that in full Pax6-/-
mutants the absence of these pioneer projections occurs
because thalamus, which normally expresses Pax6 and is
defective, does not attract these axons, whereas in Pax6
cKOs the thalamus (which is normal) does attract the pio-
neer projections. Overall, our findings argue against the
possibility that a ventral telencephalic function of Pax6 is
to regulate the development of pioneer projections from
ventral telencephalon to thalamus. They suggest that pres-
ence of these pioneer projections is not sufficient to
ensure that all thalamic axons are routed normally.
We then looked for defects of the other major feature of
the ventral telencephalon that guides thalamocortical
axons, the Islet1-expressing corridor [15]. We found a
diluted and broadened distribution of corridor cells at
E12.5, the age at which thalamic axons are first turning
towards this corridor region. The fact that the Six3A1A2-CrePage 13 of 18
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the LGE (which expresses Pax6) is important since this is
the region from which the Islet1-expressing corridor cells
migrate (green arrows in Figure 9). We can conclude,
therefore, that the cells destined for the corridor in the
Pax6 cKOs were normal and that the cause of their abnor-
mally broadened distribution into a ventral region that
expresses Pax6 is almost certainly a result of the depletion
of Pax6 in that region. The cells of the corridor migrate at
around E12.5, by which stage Pax6 was already depleted
in the mantle zone of the MGE in cKOs, implicating Pax6
in the regulation of the final distribution of the immigrant
cells. It is possible that Pax6-expressing cells ventral to the
corridor exert a repulsive influence on the incoming
Islet1-expressing LGE-derived cells. The reason that many
thalamic axons failed to enter the corridor in Pax6 cKOs
might have been the reduced peak-densities of corridor
cells. The reason that a proportion of the thalamic axons
that did successfully enter the corridor and began to travel
along it exited by taking a ventral turn might have been
the abnormal ventral dispersal of cells that should have
migrated into the corridor, thereby providing a more per-
missive environment for these axons in ventral tissue.
A fruitful focus for further work would be an analysis of
the molecular mechanisms by which the transcription fac-
tor Pax6 normally constrains the migration of corridor
cells. At present we do not understand how cells are
guided from the LGE into the corridor but it is likely that
differential cell-cell adhesion, allowing the migrating cor-
ridor cells to enter some regions but keeping them out of
others, plays a critical role. Pax6 is known to regulate the
expression of cell adhesion molecules and regulate cell
migration elsewhere in the developing telencephalon
[30,52,53], increasing the likelihood that its effects in the
ventral telencephalon are mediated via its control over the
expression of these types of molecule.
It is possible that depletion of Pax6 in ventral telen-
cephalon might affect thalamic axonal navigation rela-
tively directly through defective expression of one or more
of a potentially large number of cell surface molecules
that might affect the navigation of thalamic axons into
and through the internal capsule (reviewed in [8]).
Indeed, the effects of ventral Pax6 depletion on corridor
and thalamic axonal development might be parallel
results of the same molecular changes and defects of the
corridor might not be the cause of thalamic axonal
defects. Thus, while it is tempting to link causatively the
defects of corridor development to those of thalamic
axonal navigation in Pax6 cKOs, much more work will be
needed to establish or refute this hypothesis.
Defects of corticofugal axons in Pax6 cKOs
We found evidence that some corticofugal axons, specifi-
cally from the visual cortex, are misrouted and descend
laterally in the telencephalon rather than entering the
internal capsule. It is possible that this is caused by the
defect in the population of ascending thalamocortical
projections. Previously it has been suggested that the
intermingling of ascending thalamocortical axons with
descending corticofugal axons in the ventral telen-
cephalon is important for the guidance of each set
[3,4,8,9,21]. It seems highly plausible, therefore, that a
diminished population of ascending thalamic axons
might be unable to provide guidance for all descending
cortical axons, causing some to deviate laterally. A possi-
ble reason for a specific effect on axons from the visual
cortex is that these axons might arrive at the point of inter-
action with ascending fibers last, since they come from the
caudal cortex that is further from the internal capsule and
whose development lags behind that of more rostral cor-
tex [54]. Their late arrival might disadvantage their ability
to locate and/or interact with guidance partners in the
diminished ascending population. Clearly, other explana-
tions are possible: for example, Pax6 might be needed to
regulate the expression of molecules around the internal
capsule that attract visual corticofugal axons through this
region. Whatever the cause, it can not be an autonomous
effect in the corticofugal cells themselves since cortical
expression of Pax6 is unaffected in these cKOs.
It is conceivable that in cKOs defects of the descending
corticofugal axons, caused directly by misregulation of
expression around the internal capsule, might contribute
to the defects of the ascending thalamic axons. Previous
studies have suggested that descending corticofugal axons,
on crossing the PSPB at about E14.5, interact and help
guide ascending thalamocortical axons across the PSPB
[3,4,8,9,21]. This mechanism might contribute to defects
of thalamic axons within the internal capsule; it seems a
less likely explanation for early defects of thalamic axons
around the diencephalic-telencephalic boundary.
Conclusion
Our findings indicate an important novel function of
Pax6 along the ventral aspect of the ventral telencephalon,
constraining migrating LGE cells to form a tight Islet1-
expressing cell-dense corridor and providing normal guid-
ance cues for developing thalamocortical axons.
Materials and methods
Pax6 gene targeting
The RPCI-21 mouse PAC library [55] was screened with a
Pax6 intron 6 probe and a clone, 450-I22, was cloned into
the plasmid pZero2 (Invitrogen, Paisley, UK). A 10 kb
intron 4 and 6 containing subclone, 247B1, was identi-
fied. A 1.8 kb BamHI-SacI fragment containing part ofPage 14 of 18
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247B1 and the loxP site-flanked neomycin resistance cas-
sette from plasmid pNeoflox8 (W Muller, University of
Cologne, Germany) was inserted into an AflII site within
a non-conserved region of mouse intron 4, generating a
3.1 kb insert. A 3.3 kb SacI-BamHI fragment containing
exons 5, 5a and 6 and a 3.8 kb BamHI-NotI fragment con-
taining exon 7 were amplified from 129SvJ genomic DNA
and cloned into pCR-BluntII-TOPO (Invitrogen). The
reverse primer for the 3.3 kb fragment contained a single
loxP site linked to a BamHI site. The 3.1, 3.3 and 3.8 kb
fragments were ligated together by oriented cloning to
produce the final 10.2 kb targeting fragment (Figure 1A).
The NotI linearized targeting construct (50 μg) was elec-
troporated into E14Tg2a embryonic stem (ES) cells and
neomycin resistant cell clones isolated after 10 days in cul-
ture. Clones were screened by Southern blot to identify
those that had undergone homologous recombination
(Figure 1B, C). Chimeric mice were generated by injecting
C57BL/6 blastocysts with ES cells derived from three inde-
pendent ES clones (4-B4, 6-B5 and 6-F9) of normal kary-
otype. F1 animals were genotyped by PCR with the
forward primer 5'-AAATGGGGGTGAAGTGTGAG-3' and
reverse primer 5'-TGCATGTTGCCTGAAAGAAG-3' that
flank the single loxP site (Figure 1D) to identify founders.
Mouse mutants and breeding
The floxed Pax6 allele (designated Pax6tm1Ued using Mouse
Genome Informatics nomenclature) is referred to as
Pax6loxP and the floxed-deleted allele as Pax6loxPΔ. Lines of
mice carrying this allele and other transgenes (Six3A1A2-
Cre [39]; Zp3-Cre [35]; Z/AP reporter [40]) were back-
crossed for at least six generations to the Crl:CD-1 (ICR;
Charles River, Tranent, UK) strain and were subsequently
maintained on that background. The age of each embryo
was counted from the morning of the vaginal plug
(deemed E0.5) and confirmed by morphology. To gener-
ate conditional homozygous knockout animals (desig-
nated cKO for convenience), males either homozygous
for the floxed Pax6 allele or compound homozygous for
the floxed Pax6 and Z/AP alleles were crossed with females
compound heterozygous for the floxed Pax6 allele and
either the Six3A1A2-Cre allele or the Zp3-Cre allele. These
crosses also generated embryos that were used as controls,
that is, homozygous for the floxed Pax6 allele but lacking
the Six3A1A2-Cre allele or compound heterozygous for the
floxed Pax6 allele and the Six3A1A2-Cre allele. Neither two
copies of the floxed-undeleted allele nor a single copy of
a deleted allele caused detectable telencephalic defects.
Animal care followed institutional guidelines and UK
Home Office regulations.
Genotyping by PCR
Mice carrying the Pax6loxP allele were genotyped using
primers described above (Figure 1A, D). Mice carrying the
Pax6loxPΔ allele were genotyped using a forward primer in
intron 4 (5'-TTACCCTGGCTTTGCTTTTG-3') and a reverse
primer in intron 6 (5'-GGAGCAGTCCTTCACCTCTG-3')
downstream of the single distal loxP site (Figure 1A, D).
Cre recombinase-expressing transgenic mice were geno-
typed using primers to the Cre cassette (forward 5'-CATTT-
GGGCCAGCTAAACAT-3', reverse 5'-
ATTCTCCCACCGTCAGTACG-3'). Z/AP transgenic mice
were genotyped using primers to the hPLAP-encoding cas-
sette (forward 5'-AACCCCAGACCCTGAGTACC-3',
reverse 5'-GTGGAGTCTCGGTGGATCTC-3'). PCR reac-
tions used standard conditions.
Histology
Mouse embryos were dissected in ice-cold phosphate-
buffered saline (PBS) and then fixed by shaking in 4% (w/
v) paraformaldehyde (PFA) in PBS at 4°C overnight. Fol-
lowing fixation, embryos were dehydrated, embedded in
paraffin wax, sectioned at 10 μm in the coronal plane and
mounted on poly-L-lysine coated slides.
Immunohistochemistry
Sections were dewaxed in xylene and hydrated through
alcohols (including a 15 minute incubation in 3% (v/v)
H2O2 in methanol to aid epitope recovery) to PBS, then
boiled in 10 mM sodium citrate (pH 6) in a microwave.
After blocking in 10% normal goat serum in PBS with
0.1% (v/v) Triton X-100 (PBS-TX), sections were incu-
bated with primary antibodies at 4°C overnight. Sections
were then washed twice in PBS-TX and incubated in 10%
normal goat serum in PBS-TX for 10 minutes. Sections
were incubated in a 1:200 dilution of biotin-conjugated
goat anti-mouse secondary antibody in 10% normal goat
serum in PBS-TX for 1 hour at room temperature and
rinsed again in PBS-TX. An avidin-biotin reaction was car-
ried out using 0.05% (w/v) diaminobenzidine in tris-buff-
ered saline containing 0.02% H2O2. Sections were rinsed
in water, dehydrated, cleared in xylene and mounted. Pri-
mary antibodies were for Pax6 (1:40; AD2.38, a gift from
Professor V van Heyningen, MRC Human Genetics Unit,
Edinburgh, UK), Islet1 (1:200; DSHB, Iowa City, IA, USA)
and Mash1 (1:100; BD Pharmingen, San Jose, CA, USA).
Alkaline phosphatase staining
To reveal hPLAP activity, embryos were first dissected in
ice cold PBS. Brains from embryos older than E12.5 were
removed from their skulls and bisected parasagittally
prior to fixation for 0.5 to 2 hours in 4% PFA on ice on a
shaking platform. Tissue was then rinsed in ice cold PBS
and embedded in 4% (w/v) agarose in PBS in blocks.
Blocks were sectioned coronally on a vibratome at 100 to
200 μm. Sections were collected into wells containing PBS
and then stained for hPLAP activity as described previ-
ously [40]. Sections were post-fixed in 2% (v/v) glutaral-
dehyde in PBS for 2 hours at 4°C, rinsed several times inPage 15 of 18
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glycerol:PBS and then mounted in 9:1 glycerol:PBS.
Carbocyanine dye injection and analysis
Brains were fixed overnight by shaking in 4% (w/v) PFA at
4°C. Two different methods were used to label the tha-
lamocortical tract. In the first, whole brains were dissected
away from their skulls and a medial slice of cortex was
removed on both sides of the midline to expose the dorsal
surface of the thalamus. Single crystals of the lipophilic
tracer DiI were injected at three symmetrical positions
along the rostrocaudal extent of the thalamus. In the sec-
ond, whole brains were bisected parasagittally to expose
the dorsoventral aspect of the thalamus at the midline.
Injections of single crystals were made at three positions
along the dorsoventral extent of the dorsal thalamus. In
some experiments injections of DiI and the lipophilic
tracer DiA were made in the cortex. All injections were
made by picking up single DiI crystals with pulled glass
capillaries and lancing the tissue at each desired location
to deposit the crystal. Dyes were allowed to diffuse at
room temperature for 4 to 6 weeks in 4% (w/v) PFA in
PBS, rinsed in PBS, embedded in agarose, sectioned coro-
nally on a vibratome at 100 to 200 μm, counterstained
with 0.002% (w/v) bisbenzimide in PBS for 30 minutes at
room temperature and cleared through glycerol.
Microscopy
All images were acquired using an epifluorescence micro-
scope mounted with a digital camera. In epifluorescence,
bisbenzimide appears blue (UV filter) and DiI appears
red/orange (rhodamine filter).
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